Lv4
696 积分 2024-03-15 加入
肝细胞癌术后辅助治疗专家共识（2026版）
1个月前
已完结
Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study
1个月前
已完结
Hepatotoxicity From Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation
1个月前
已完结
Adjuvant transarterial chemoembolization for hepatocellular carcinoma following curative resection: A randomized, open-label, phase 3 trial
1个月前
已完结
Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives
4个月前
已完结
Efficacy and safety of radiotherapy combined with immune checkpoint inhibitors for advanced or unresectable hepatocellular carcinoma: A systematic review and meta-analysis
4个月前
已完结
Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma
4个月前
已完结
Safety of Combined Yttrium-90 Radioembolization and Immune Checkpoint Inhibitor Immunotherapy for Hepatocellular Carcinoma
5个月前
已完结
Selective Internal Radiation Therapy Combined with Immune Checkpoint Inhibitors in the Treatment of Hepatocellular Carcinoma: A Systematic Review and Single-Arm Meta-Analysis
5个月前
已完结
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1
5个月前
已完结
皖公网安备34019202002308
